United States Non-Invasive Prenatal Testing (NIPT) Market Research Report 2025 - 2033

DELHI, India - Oct. 23, 2024 - PRLog -- United States Non-Invasive Prenatal Testing Market Competitive Landscape

As of 2024, the Non-Invasive Prenatal Testing (NIPT) market in the United States has been experiencing significant growth, driven by technological advancements and increasing demand for early and accurate prenatal screening methods.
Key Player's Profiles

• Illumina, Inc.
• Natera, Inc.
• Quest Diagnostics
• Myriad Genetics, Inc.
• Centogene
• GenPath
• PerkinElmer
• Yourgene Health
• Invitae Corporation
• Agilent Technologies
• Ariosa Diagnostics (Roche)
• Laboratory Corporation of America Holdings(Labcorp)

Scope of the Report:

• The market size of the non-invasive prenatal testing market in the United States with an eight-year forecast
• Insights into the market determinants stimulating the market for non-invasive prenatal testing in the United States
• The market size of the average risk non–invasive prenatal testing market in the United States with an eight year forecast
• The market size of the high-risk non–invasive prenatal testing market in the United States with an eight year forecast
• The report analyse the total number of non–invasive prenatal testing performed in the United States with eight year forecast
• The report analyse the total number of average-risk non–invasive prenatal testing performed in the United States with eight year forecast
• The report examine the total number of high-risk non–invasive prenatal testing performed in the United States with an eight year forecast
• The report study market potential and opportunities for this innovation-driven non–invasive prenatal testing market in the United States with eight year forecast
• The report contains in-depth analysis of average and high-risk potential non–invasive prenatal testing market in the United States with an eight year forecast
• Thoroughly evaluate the overall potential number of non–invasive prenatal testing performed in the United States with an eight year forecast
• The report explore average and high-risk potential number of the non–invasive prenatal testing performed in the United States with an eight year forecast
• The report study regulatory framework of the United States non–invasive prenatal testing market
• The report analyse reimbursement patterns of the United States non–invasive prenatal testing market
• Tracks competitive developments, approaches, recent industry developments, mergers & acquisitions, collaboration deals, partnership deals, distribution, exclusive, and licensing agreement
• A Comprehensive list of key market players along with the analysis of their current nipt test portfolios, business overview, and latest development

More Details @ https://dpiresearch.com/report/united-non-invasive-prenat...